Retraction
miRNA-302b Suppresses Human Hepatocellular Carcinoma by Targeting AKT2
Paper Information
Record ID:
58275
Author(s):
Publication Date:
February 19, 2014
Retraction Date:
November 01, 2024
(1.0 year years ago)
Subjects:
Institutions:
- Department of Genetics and Molecular Biology, Xi'an Jiaotong University, School of Medicine, Ministry of Education, Xi'an, China
- Department of Hepatobiliary Surgery, First Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Ministry of Education, Xi'an, China
- Department of Oncology, First Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Ministry of Education, Xi'an, China
- Engineering Research Center of Biotherapy and Translational Medicine of Shaanxi Province, Ministry of Education, Xi'an, China
- Key Laboratory of Environmentally and Genetically Associated Diseases at Xi'an, Jiaotong University, Ministry of Education, Xi'an, China
- Department of Experimental Therapeutics, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas
- Division of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, California
Countries:
Article Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1158/1541-7786.MCR-24-0723Citations (57)
57
Total Citations0
Post-Retraction55
Pre-Retraction1
Same DayPaper citing miRNA-302b Suppresses Human Hepatocellular Carcino...
Unknown Authors
Unknown Journal
Published: Unknown
Retraction: miRNA-302b Suppresses Human Hepatocellular Carcinoma by Targeting AKT2
Lumin Wang, Jiayi Yao, Xiaogang Zhang et al. (10 authors)
Molecular Cancer Research
Published: Nov 2024
Same day as retraction
Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma
Mete Ucdal
Hepatology forum/Hepatology forum (Online)
Open Access
Published: Jan 2024
1 citation
1 citation
305 days before retraction
miR-153-3p suppresses the differentiation and proliferation of neural stem cells via targeting GPR55
Xiaolin Dong, Hui Wang, Liping Zhan et al. (8 authors)
Aging
Open Access
Published: Aug 2023
4 citations
4 citations
432 days before retraction
Circ_0073228 serves as a competitive endogenous ribonucleic acid to facilitate proliferation and inhibit apoptosis of hepatocellular carcinoma cells by the miR‐139‐5p/deoxyribonuclease II axis
Lu Bai, Zujiang Yu, Qinggang Li et al. (8 authors)
The Journal of Gene Medicine
Published: Mar 2023
6 citations
6 citations
581 days before retraction
Potential role of microRNAs in selective hepatic insulin resistance: From paradox to the paradigm
Palihaderu Arachchige Dineth Supasan Palihaderu, Balapuwaduge Isuru Layan Madusanka Mendis, Jayasekara Mudiyanselage Krishanthi Jayarukshi Kumari Premarathne et al. (11 authors)
Frontiers in Endocrinology
Open Access
Published: Nov 2022
1 citation
1 citation
711 days before retraction
MBD1/HDAC3-miR-5701-FGFR2 axis promotes the development of gastric cancer
Changan Zhao, Jiyu Miao, Ruifang Sun et al. (11 authors)
Aging
Open Access
Published: Jul 2022
6 citations
6 citations
833 days before retraction
Hepatocellular Carcinoma: The Role of MicroRNAs
Sharad Khare, Tushar Khare, Raghu Ramanathan et al. (4 authors)
Biomolecules
Open Access
Published: Apr 2022
29 citations
29 citations
919 days before retraction
Hsa_circRNA_103124 Upregulation in Crohn’s Disease Promotes Cell Proliferation and Inhibits Autophagy by Regulating the Hsa-miR-650/AKT2 Signaling Pathway
Juan Juan Yin, Fu-yi Tong, Yulan Ye et al. (8 authors)
Frontiers in Genetics
Open Access
Published: Nov 2021
4 citations
4 citations
1092 days before retraction
Knockdown of long non-coding RNA LINC01006 represses the development of hepatocellular carcinoma by modulating the miR-194-5p/CADM1 axis
Zhaoxia Sun, Li Zhao, Shuang Wang et al. (4 authors)
Annals of Hepatology
Open Access
Published: Oct 2021
7 citations
7 citations
1100 days before retraction
miR-100 Suppresses the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma Cells via Targeting CXCR7
Yiman Ge, Jia Shu, Gang Shi et al. (6 authors)
Journal of Immunology Research
Open Access
Published: Jul 2021
8 citations
8 citations
1203 days before retraction
miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression
Zhenzhen Wang, Xintao Jing, Zhenghao Zhao et al. (7 authors)
Journal of Clinical Images and Medical Case Reports
Open Access
Published: May 2021
1274 days before retraction
LncUBE2R2-AS1 acts as a microRNA sponge of miR-302b to promote HCC progression via activation EGFR-PI3K-AKT signaling pathway
Zhe Wu, Zhihong Wei, Shaohua Chen
Cell Cycle
Open Access
Published: Aug 2020
11 citations
11 citations
1531 days before retraction
MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer
Alessandra Cataldo, Sandra Romero‐Córdoba, Ilaria Plantamura et al. (7 authors)
Cancers
Open Access
Published: Aug 2020
16 citations
16 citations
1542 days before retraction
Regulatory mechanism of tumor suppressor gene miR-302b in malignant tumors
Min-Na Li, Ning Lü, Yixuan Wang et al. (6 authors)
Shijie huaren xiaohua zazhi
Open Access
Published: Jul 2020
1557 days before retraction
LncRNA SNHG7 promotes glioma cells viability, migration and invasion by regulating miR-342-3p/AKT2 axis
Gaopeng Cheng, Jian Zheng, Long Wang
International Journal of Neuroscience
Published: Jul 2020
8 citations
8 citations
1579 days before retraction
HOXD3 was negatively regulated by YY1 recruiting HDAC1 to suppress progression of hepatocellular carcinoma cells via ITGA2 pathway
Lumin Wang, Yi Gao, Xiaoge Zhao et al. (12 authors)
Cell Proliferation
Open Access
Published: Jun 2020
27 citations
27 citations
1598 days before retraction
Role of miR-302/367 cluster in human physiology and pathophysiology
Menghuan Guo, Lu Gan, Jing Si et al. (8 authors)
Acta Biochimica et Biophysica Sinica
Open Access
Published: May 2020
16 citations
16 citations
1624 days before retraction
Identification of the possible therapeutic targets in the insulin-like growth factor 1 receptor pathway in a cohort of Egyptian hepatocellular carcinoma complicating chronic hepatitis C type 4
Nada Ahmed, Dalal Elkaffash, Mona Abdel‐Hadi et al. (9 authors)
Drug Target Insights
Open Access
Published: Apr 2020
2 citations
2 citations
1668 days before retraction
The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years
Song Zhang, Ying Zhou, Yanan Wang et al. (9 authors)
Briefings in Bioinformatics
Published: Feb 2020
24 citations
24 citations
1722 days before retraction
Application of the microRNA‐302/367 cluster in cancer therapy
Jiajia Liu, Ying Wang, Ping Ji et al. (4 authors)
Cancer Science
Open Access
Published: Jan 2020
26 citations
26 citations
1747 days before retraction
MyoD1 suppresses cell migration and invasion by inhibiting FUT4 transcription in human gastric cancer cells
Fei Wu, Yannan Qin, Qiuyu Jiang et al. (15 authors)
Cancer Gene Therapy
Open Access
Published: Dec 2019
16 citations
16 citations
1786 days before retraction
HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells
Martin Kučírek, Alireza Jian Bagherpoor, Josef Jaroš et al. (5 authors)
The FASEB Journal
Open Access
Published: Oct 2019
19 citations
19 citations
1833 days before retraction
CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression
Yang Su, Xiurui Lv, Wei Yin et al. (7 authors)
Aging
Open Access
Published: Oct 2019
190 citations
190 citations
1858 days before retraction
Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis
Huayu Wu, Kai-teng Cai, Jie Ma et al. (7 authors)
Pathology - Research and Practice
Published: Apr 2019
11 citations
11 citations
2013 days before retraction
MicroRNA‐520c‐3p functions as a novel tumor suppressor in lung adenocarcinoma
Xiaofeng Li, Qiang Fu, Hui Li et al. (8 authors)
FEBS Journal
Open Access
Published: Apr 2019
29 citations
29 citations
2039 days before retraction
MicroRNA‑302a upregulation mediates chemo‑resistance in prostate cancer cells
Yuqi Wu, Li Hu, Zizhen Qin et al. (4 authors)
Molecular Medicine Reports
Open Access
Published: Mar 2019
9 citations
9 citations
2045 days before retraction
Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR‐140‐5p
Zheng‐Yang Wang, Zhu Zhu, Huafei Wang et al. (8 authors)
Journal of Cellular Physiology
Published: Mar 2019
26 citations
26 citations
2061 days before retraction
The microRNA and the perspectives of miR-302
Emily Yen Yu Chen, Jack S. Chen, Shao‐Yao Ying
Heliyon
Open Access
Published: Jan 2019
14 citations
14 citations
2131 days before retraction
Fentanyl inhibits proliferation and invasion via enhancing miR‑302b expression in esophageal squamous cell carcinoma
Ning Wang, Zhenni Zhang, Jianrui Lv
Oncology Letters
Open Access
Published: May 2018
12 citations
12 citations
2375 days before retraction
CREBRF promotes the proliferation of human gastric cancer cells via the AKT signaling pathway
Jiming Han, Lu Zhang, Jing Zhang et al. (9 authors)
Cellular and Molecular Biology
Open Access
Published: Apr 2018
27 citations
27 citations
2377 days before retraction
The MicroRNA
Shao‐Yao Ying, Donald C. Chang, Shi-Lung Lin
Methods in molecular biology
Published: Jan 2018
25 citations
25 citations
2496 days before retraction
Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion
Qian Li, Pengzhan Ran, Xiyu Zhang et al. (9 authors)
Cellular Physiology and Biochemistry
Open Access
Published: Jan 2018
41 citations
41 citations
2496 days before retraction
Triangle of AKT2, miRNA, and Tumorigenesis in Different Cancers
Maryam Honardoost, Seyed Mohammad Ali Hosseini Rad
Applied Biochemistry and Biotechnology
Published: Dec 2017
24 citations
24 citations
2524 days before retraction
miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer
Jin Huang, Yijing He, Howard L. McLeod et al. (15 authors)
BMC Cancer
Open Access
Published: Dec 2017
57 citations
57 citations
2527 days before retraction
MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2
Yuanlong Xie, Wenchao Sun, Zhouming Deng et al. (6 authors)
Scientific Reports
Open Access
Published: Oct 2017
41 citations
41 citations
2578 days before retraction
Paper citing miRNA-302b Suppresses Human Hepatocellular Carcino...
Unknown Authors
Unknown Journal
Published: Sep 2017
2589 days before retraction
Let-7a inhibits migration, invasion and tumor growth by targeting AKT2 in papillary thyroid carcinoma
Bin Zhou, Hailin Shan, Ying Su et al. (6 authors)
Oncotarget
Open Access
Published: Jul 2017
27 citations
27 citations
2666 days before retraction
Paper citing miRNA-302b Suppresses Human Hepatocellular Carcino...
Unknown Authors
Unknown Journal
Published: Feb 2017
2825 days before retraction
MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer
Bo Guo, Zhenghao Zhao, Zhen Wang et al. (8 authors)
Cellular Physiology and Biochemistry
Open Access
Published: Jan 2017
42 citations
42 citations
2861 days before retraction
MiRNA expression changes in arsenic-induced skin cancer in vitro and in vivo.
Laila Al‐Eryani
Unknown Journal
Open Access
Published: Jan 2017
1 citation
1 citation
2861 days before retraction
MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A
Lumin Wang, Jiayi Yao, Hongfei Sun et al. (7 authors)
Oncology Letters
Open Access
Published: Nov 2016
59 citations
59 citations
2900 days before retraction
A MicroRNA302-367-Erk1/2-Klf2-S1pr1 Pathway Prevents Tumor Growth via Restricting Angiogenesis and Improving Vascular Stability
Jingjiang Pi, Ting Tao, Tao Zhuang et al. (18 authors)
Circulation Research
Open Access
Published: Oct 2016
38 citations
38 citations
2935 days before retraction
MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma
Qianqian Zhang, Shixing Zhao, Xiaoli Pang et al. (4 authors)
Oncology Reports
Open Access
Published: Dec 2015
49 citations
49 citations
3243 days before retraction
miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells
Yan Wang, Lin Zhao, Qinghuan Xiao et al. (9 authors)
Gynecologic Oncology
Published: Nov 2015
59 citations
59 citations
3261 days before retraction
miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response
Alessandra Cataldo, Douglas G. Cheung, Andrea Balsari et al. (8 authors)
Oncotarget
Open Access
Published: Nov 2015
76 citations
76 citations
3264 days before retraction
Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin
Baolai Zhang, Shuhong Dong, Zhongxin Li et al. (8 authors)
Journal of Translational Medicine
Open Access
Published: Nov 2015
54 citations
54 citations
3284 days before retraction
MicroRNA-302b Enhances the Sensitivity of Hepatocellular Carcinoma Cell Lines to 5-FU via Targeting Mcl-1 and DPYD
Donghui Cai, Kang He, Sue Chang et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Oct 2015
35 citations
35 citations
3314 days before retraction
Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients
K Sugimachi, Shotaro Sakimura, Akira Tomokuni et al. (16 authors)
Journal of Clinical Medicine
Open Access
Published: Aug 2015
5 citations
5 citations
3367 days before retraction
miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells
Lumin Wang, Jiayi Yao, Hongfei Sun et al. (8 authors)
Tumor Biology
Published: Aug 2015
23 citations
23 citations
3374 days before retraction
Quick Stats
Total Citations:
57
Years Since Retraction:
1.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025